Summary
57 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $5.34M against $739.0K.
- The share price is below the Bulios Fair Price.
- Revenue grew by 14% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 0.9% a year over 5 years. Over the last 3 years it grew by 14% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.26M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Human Care 91%
- Animal Care 9.5%
By region
- Latin America 100%
Human Care brings in 91% of revenue.
Segments in detail